NeueHealth Q2 2024 GAAP EPS $(6.42) Misses $(2.76) Estimate, Sales $225.991M Miss $252.477M Estimate
Portfolio Pulse from Benzinga Newsdesk
NeueHealth reported a Q2 2024 GAAP EPS of $(6.42), significantly missing the $(2.76) estimate. Sales were $225.991 million, also missing the $252.477 million estimate.
August 07, 2024 | 10:47 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
NeueHealth's Q2 2024 earnings report showed a significant miss on both EPS and sales estimates, which is likely to negatively impact the stock price in the short term.
The significant miss on both EPS and sales estimates indicates weaker-than-expected financial performance, which is likely to lead to a negative market reaction and a decline in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100